Erythropoietin production by PDGFR-β+ cells

Pflugers Archiv European Journal of Physiology

Volumn 468, Issue 8, 2016, Pages 1479-1487

  Gerl, Katharina ^a   Nolan, Karen A ^b   Karger, Christian ^a   Fuchs, Michaela ^a   Wenger, Roland H ^b   Stolt, Claus C ^c   Willam, Carsten ^c   Kurtz, Armin ^a   Kurt, Birgül ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Adrenal gland; Erythropoietin; HIF 2; Inducible deletion of Vhl; Kidney; PDGFR expressing cells

Indexed keywords

ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; MESSENGER RNA; PROLYL HYDROXYLASE INHIBITOR; VON HIPPEL LINDAU PROTEIN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR;

ADRENAL GLAND; ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL HETEROGENEITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HEMATOCRIT; HORMONE SYNTHESIS; KIDNEY CELL; MOUSE; NONHUMAN; PDGFR BETA CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; ANIMAL; DIAGNOSTIC IMAGING; KIDNEY; METABOLISM;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; ERYTHROPOIETIN; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KIDNEY; MICE; PROLYL-HYDROXYLASE INHIBITORS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RNA, MESSENGER; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 84969930950     PISSN: 00316768     EISSN: 14322013     Source Type: Journal    
DOI: 10.1007/s00424-016-1829-2     Document Type: Article

References (39)

1. Asada N, Takase M, Nakamura J, Oguchi A, Asada M, Suzuki N, Yamamura K, Nagoshi N, Shibata S, Rao TN et al (2011) Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice. J Clin Invest 121:3981–3990. doi:10.1172/JCI57301
2. Bachmann S, Le Hir M, Eckardt KU (1993) Co-localization of erythropoietin mRNA and ecto-5′-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin. J Histochem Cytochem 41:335–341
3. Caro J, Brown S, Miller O, Murray T, Erslev AJ (1979) Erythropoietin levels in uremic nephric and anephric patients. J Lab Clin Med 93:449–458
4. Chang YT, Yang CC, Pan SY, Chou YH, Chang FC, Lai CF, Tsai MH, Hsu HL, Lin CH, Chiang WC et al (2016) DNA methyltransferase inhibition restores erythropoietin production in fibrotic murine kidneys. J Clin Invest 126:721–731. doi:10.1172/JCI82819
5. Chavez JC, Baranova O, Lin J, Pichiule P (2006) The transcriptional activator hypoxia inducible factor 2 (HIF-2/EPAS-1) regulates the oxygen-dependent expression of erythropoietin in cortical astrocytes. J Neurosci 26:9471–9481. doi:10.1523/JNEUROSCI.2838-06.2006
6. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159. doi:10.1006/abio.1987.9999
7. Cotes PM, Pippard MJ, Reid CDL, Winearls CG, Oliver DO, Royston JP (1989) Characterization of the anemia of chronic renal-failure and the mode of its correction by a preparation of human erythropoietin (R-Huepo)—an investigation of the pharmacokinetics of intravenous erythropoietin and its effects on erythrokinetics. Q J Med 70:113–137
8. Del Vecchio L, Locatelli F (2014) New treatment approaches in chronic kidney disease-associated anaemia. Expert Opin Biol Ther 14:687–696. doi:10.1517/14712598.2014.892577
9. Eckardt KU, Koury ST, Tan CC, Schuster SJ, Kaissling B, Ratcliffe PJ, Kurtz A (1993) Distribution of erythropoietin producing cells in rat kidneys during hypoxic hypoxia. Kidney Int 43:815–823
10. Eschbach JW, Bourdeau J, Coe F, Toback G, Cohen JJ, Pochedly C, Garella S, Lau K, Bushinsky D, Sprague S et al (1989) The anemia of chronic renal-failure—patho-physiology and the effects of recombinant erythropoietin. Kidney Int 35:134–148. doi:10.1038/ki.1989.18
11. Fisher JW (1998) A quest for erythropoietin over nine decades. Annu Rev Pharmacol Toxicol 38:1–20. doi:10.1146/annurev.pharmtox.38.1.1
12. Gerl K, Miquerol L, Todorov VT, Hugo CP, Adams RH, Kurtz A, Kurt B (2015) Inducible glomerular erythropoietin production in the adult kidney. Kidney Int 88:1345–1355. doi:10.1038/ki.2015.274
13. Gruber M, Hu CJ, Johnson RS, Brown EJ, Keith B, Simon MC (2007) Acute postnatal ablation of Hif-2alpha results in anemia. Proc Natl Acad Sci U S A 104:2301–2306. doi:10.1073/pnas.0608382104
14. Haase VH (2010) Hypoxic regulation of erythropoiesis and iron metabolism. Am J Physiol Renal 299:F1–F13. doi:10.1152/ajprenal.00174.2010
15. Haase VH, Glickman JN, Socolovsky M, Jaenisch R (2001) Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. Proc Natl Acad Sci U S A 98:1583–1588. doi:10.1073/pnas.98.4.1583
16. Humphreys BD, Lin SL, Kobayashi A, Hudson TE, Nowlin BT, Bonventre JV, Valerius MT, McMahon AP, Duffield JS (2010) Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 176:85–97. doi:10.2353/ajpath.2010.090517
17. Kapitsinou PP, Liu Q, Unger TL, Rha J, Davidoff O, Keith B, Epstein JA, Moores SL, Erickson-Miller CL, Haase VH (2010) Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia. Blood 116:3039–3048. doi:10.1182/blood-2010-02-270322
18. Kobayashi A, Mugford JW, Krautzberger AM, Naiman N, Liao J, McMahon AP (2014) Identification of a multipotent self-renewing stromal progenitor population during mammalian kidney organogenesis. Stem Cell Rep 3:650–662. doi:10.1016/j.stemcr.2014.08.008
19. Le Hir M, Eckardt KU, Kaissling B, Koury ST, Kurtz A (1991) Structure-function correlations in erythropoietin formation and oxygen sensing in the kidney. Klin Wochenschr 69:567–575
20. Matsuoka T, Ahlberg PE, Kessaris N, Iannarelli P, Dennehy U, Richardson WD, McMahon AP, Koentges G (2005) Neural crest origins of the neck and shoulder. Nature 436:347–355. doi:10.1038/nature03837
21. Maxwell PH, Osmond MK, Pugh CW, Heryet A, Nicholls LG, Tan CC, Doe BG, Ferguson DJP, Johnson MH, Ratcliffe PJ (1993) Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney Int 44:1149–1162. doi:10.1038/ki.1993.362
22. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271–275
23. McClellan W, Aronoff SL, Bolton WK, Hood S, Lorber DL, Tang KL, Tse TF, Wasserman B, Leiserowitz M (2004) The prevalence of anemia in patients with chronic kidney disease. Curr Med Res Opin 20:1501–1510. doi:10.1185/030079904x2783
24. Muller SM, Stolt CC, Terszowski G, Blum C, Amagai T, Kessaris N, Iannarelli P, Richardson WD, Wegner M, Rodewald HR (2008) Neural crest origin of perivascular mesenchyme in the adult thymus. J Immunol 180:5344–5351
25. Nangaku M, Eckardt KU (2006) Pathogenesis of renal anemia. Semin Nephrol 26:261–268. doi:10.1016/j.semnephrol.2006.06.001
26. Nguyen AQ, Cherry BH, Scott GF, Ryou MG, Mallet RT (2014) Erythropoietin: powerful protection of ischemic and post-ischemic brain. Exp Biol Med (Maywood) 239:1461–1475. doi:10.1177/1535370214523703
27. Noguchi CT, Asavaritikrai P, Teng R, Jia Y (2007) Role of erythropoietin in the brain. Crit Rev Oncol Hematol 64:159–171. doi:10.1016/j.critrevonc.2007.03.001
28. Obara N, Suzuki N, Kim K, Nagasawa T, Imagawa S, Yamamoto M (2008) Repression via the GATA box is essential for tissue-specific erythropoietin gene expression. Blood 111:5223–5232. doi:10.1182/blood-2007-10-115857
29. Paliege A, Rosenberger C, Bondke A, Sciesielski L, Shina A, Heyman SN, Flippin LA, Arend M, Klaus SJ, Bachmann S (2010) Hypoxia-inducible factor-2 alpha-expressing interstitial fibroblasts are the only renal cells that express erythropoietin under hypoxia-inducible factor stabilization. Kidney Int 77:312–318. doi:10.1038/ki.2009.460
30. Pan X, Suzuki N, Hirano I, Yamazaki S, Minegishi N, Yamamoto M (2011) Isolation and characterization of renal erythropoietin-producing cells from genetically produced anemia mice. PLoS One 6, e25839. doi:10.1371/journal.pone.0025839
31. Rankin EB, Biju MP, Liu Q, Unger TL, Rha J, Johnson RS, Simon MC, Keith B, Haase VH (2007) Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J Clin Invest 117:1068–1077. doi:10.1172/JCI30117
32. Ryan HE, Poloni M, McNulty W, Elson D, Gassmann M, Arbeit JM, Johnson RS (2000) Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res 60:4010–4015
33. Sheikh AQ, Misra A, Rosas IO, Adams RH, Greif DM (2015) Smooth muscle cell progenitors are primed to muscularize in pulmonary hypertension. Sci Transl Med 7:308ra159. doi:10.1126/scitranslmed.aaa9712
34. Souma T, Yamazaki S, Moriguchi T, Suzuki N, Hirano I, Pan X, Minegishi N, Abe M, Kiyomoto H, Ito S et al (2013) Plasticity of renal erythropoietin-producing cells governs fibrosis. J Am Soc Nephrol 24:1599–1616. doi:10.1681/ASN.2013010030
35. Srinivas S, Watanabe T, Lin CS, William CM, Tanabe Y, Jessell TM, Costantini F (2001) Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol 1:4
36. Suzuki N (2015) Erythropoietin gene expression: developmental-stage specificity, cell-type specificity, and hypoxia inducibility. Tohoku J Exp Med 235:233–240. doi:10.1620/tjem.235.233
37. Tanimoto K, Makino Y, Pereira T, Poellinger L (2000) Mechanism of regulation of the hypoxia-inducible factor-l alpha by the von Hippel-Lindau tumor suppressor protein. EMBO J 19:4298–4309. doi:10.1093/emboj/19.16.4298
38. Yamazaki S, Souma T, Hirano I, Pan XQ, Minegishi N, Suzuki N, Yamamoto M (2013) A mouse model of adult-onset anaemia due to erythropoietin deficiency. Nat Commun 4: 1950. doi: 10.1038/ncomms2950
39. Yeo EJ, Cho YS, Kim MS, Park JW (2008) Contribution of HIF-1alpha or HIF-2alpha to erythropoietin expression: in vivo evidence based on chromatin immunoprecipitation. Ann Hematol 87:11–17. doi:10.1007/s00277-007-0359-6